Nuritas, a Dublin, Ireland-based biotech startup, raised $3.2m in funding.
The round was led by New Protein Capital with participation from Silicon Valley investor Ali Partovi.
The company intends to use the funds to accelerate development of its platform.
Led by Dr. Nora Khaldi, founder, and Emmet Browne, CEO, Nuritas provides a platform that combines artificial intelligence and DNA sequencing to discover particular molecules – called peptides – in natural sources such as food that have scientifically validated health benefits.
The company has already developed and patented health-improving ingredients that can address global challenges as broad as inflammation, diabetes, ageing and MRSA, amongst others.